INDSWFTLAB
Ind-Swift Laboratories Limited
Pharmaceuticals
Share price
₹330
Market cap
₹2,864 Cr
1Y return
▲ 231%
A pharmaceutical manufacturer engaged in the production of bulk drugs and formulations, Ind-Swift Laboratories operates across India's medicinal compounds sector. Established in 1995, the company focuses on developing and supplying active pharmaceutical ingredients and finished dosage forms to both domestic and international markets. Its integrated operations span research, manufacturing, quality control, and distribution within the broader pharmaceutical value chain.
Investors holding Ind-Swift Laboratories Limited
2.96%
Latest move
Nova GlobalNew position
Nova Global entered Ind-Swift Laboratories with 25,72,991 shares, a 2.96% stake, valued at approximately ₹59.63 Cr.
Sign in to read more
Whales made 2 more moves in Ind-Swift Laboratories Limited
Sign in to see who is buying and selling.
Sign in to find out